NU SKIN ENTERPRISES INC - A (NUS) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:NUS - US67018T1051 - Common Stock
10 USD
-0.02 (-0.2%)
9.9994 USD
0 (-0.01%)
NUS gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 35 industry peers in the Personal Care Products industry. Both the profitability and the financial health of NUS get a neutral evaluation. Nothing too spectacular is happening here. NUS has a bad growth rate and is valued cheaply.
1. Profitability
1.1 Basic Checks
NUS had positive earnings in the past year.
In the past year NUS had a positive cash flow from operations.
NUS had positive earnings in 4 of the past 5 years.
In the past 5 years NUS always reported a positive cash flow from operatings.
1.2 Ratios
NUS has a Return On Assets of 7.69%. This is in the better half of the industry: NUS outperforms 77.14% of its industry peers.
The Return On Equity of NUS (13.70%) is better than 82.86% of its industry peers.
NUS has a Return On Invested Capital of 4.08%. This is comparable to the rest of the industry: NUS outperforms 54.29% of its industry peers.
NUS had an Average Return On Invested Capital over the past 3 years of 5.22%. This is significantly below the industry average of 12.46%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.69% | ||
| ROE | 13.7% | ||
| ROIC | 4.08% |
ROA(3y)-1.25%
ROA(5y)2.75%
ROE(3y)-3.26%
ROE(5y)5.55%
ROIC(3y)5.22%
ROIC(5y)9.29%
1.3 Margins
NUS has a better Profit Margin (7.02%) than 77.14% of its industry peers.
The Operating Margin of NUS (3.87%) is comparable to the rest of the industry.
NUS's Operating Margin has declined in the last couple of years.
NUS has a Gross Margin of 67.20%. This is comparable to the rest of the industry: NUS outperforms 51.43% of its industry peers.
NUS's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.87% | ||
| PM (TTM) | 7.02% | ||
| GM | 67.2% |
OM growth 3Y-34.86%
OM growth 5Y-23.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-2.13%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NUS is destroying value.
NUS has more shares outstanding than it did 1 year ago.
NUS has less shares outstanding than it did 5 years ago.
NUS has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.78 indicates that NUS is not in any danger for bankruptcy at the moment.
NUS's Altman-Z score of 3.78 is fine compared to the rest of the industry. NUS outperforms 74.29% of its industry peers.
NUS has a debt to FCF ratio of 4.29. This is a neutral value as NUS would need 4.29 years to pay back of all of its debts.
NUS has a better Debt to FCF ratio (4.29) than 82.86% of its industry peers.
A Debt/Equity ratio of 0.26 indicates that NUS is not too dependend on debt financing.
NUS's Debt to Equity ratio of 0.26 is in line compared to the rest of the industry. NUS outperforms 48.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 4.29 | ||
| Altman-Z | 3.78 |
ROIC/WACC0.55
WACC7.45%
2.3 Liquidity
NUS has a Current Ratio of 2.15. This indicates that NUS is financially healthy and has no problem in meeting its short term obligations.
NUS has a Current ratio of 2.15. This is comparable to the rest of the industry: NUS outperforms 51.43% of its industry peers.
NUS has a Quick Ratio of 1.45. This is a normal value and indicates that NUS is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.45, NUS perfoms like the industry average, outperforming 54.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.15 | ||
| Quick Ratio | 1.45 |
3. Growth
3.1 Past
NUS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 64.29%, which is quite impressive.
The earnings per share for NUS have been decreasing by -22.85% on average. This is quite bad
NUS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.10%.
The Revenue has been decreasing by -6.47% on average over the past years.
EPS 1Y (TTM)64.29%
EPS 3Y-41.01%
EPS 5Y-22.85%
EPS Q2Q%100%
Revenue 1Y (TTM)-12.1%
Revenue growth 3Y-13.71%
Revenue growth 5Y-6.47%
Sales Q2Q%-15.33%
3.2 Future
Based on estimates for the next years, NUS will show a very strong growth in Earnings Per Share. The EPS will grow by 36.15% on average per year.
NUS is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -5.71% yearly.
EPS Next Y49.72%
EPS Next 2Y36.15%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-11.95%
Revenue Next 2Y-5.71%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 7.25 indicates a rather cheap valuation of NUS.
Compared to the rest of the industry, the Price/Earnings ratio of NUS indicates a rather cheap valuation: NUS is cheaper than 91.43% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.65, NUS is valued rather cheaply.
The Price/Forward Earnings ratio is 6.35, which indicates a rather cheap valuation of NUS.
NUS's Price/Forward Earnings ratio is rather cheap when compared to the industry. NUS is cheaper than 85.71% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.45, NUS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.25 | ||
| Fwd PE | 6.35 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, NUS is valued cheaply inside the industry as 91.43% of the companies are valued more expensively.
94.29% of the companies in the same industry are more expensive than NUS, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.28 | ||
| EV/EBITDA | 4.04 |
4.3 Compensation for Growth
NUS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
NUS's earnings are expected to grow with 36.15% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.15
PEG (5Y)N/A
EPS Next 2Y36.15%
EPS Next 3YN/A
5. Dividend
5.1 Amount
NUS has a Yearly Dividend Yield of 2.53%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 7.49, NUS pays a bit more dividend than its industry peers.
NUS's Dividend Yield is comparable with the S&P500 average which is at 2.41.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.53% |
5.2 History
The dividend of NUS decreases each year by -30.50%.
NUS has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-30.5%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
NUS pays out 10.87% of its income as dividend. This is a sustainable payout ratio.
DP10.87%
EPS Next 2Y36.15%
EPS Next 3YN/A
10
-0.02 (-0.2%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners75.02%
Inst Owner Change1.34%
Ins Owners2.08%
Ins Owner Change3.44%
Market Cap495.00M
Revenue(TTM)1.56B
Net Income(TTM)109.61M
Analysts45
Price Target7.65 (-23.5%)
Short Float %4.77%
Short Ratio4.33
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.53% |
Yearly Dividend0.24
Dividend Growth(5Y)-30.5%
DP10.87%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)42.99%
Min EPS beat(2)12.21%
Max EPS beat(2)73.77%
EPS beat(4)4
Avg EPS beat(4)59.11%
Min EPS beat(4)12.21%
Max EPS beat(4)76.64%
EPS beat(8)7
Avg EPS beat(8)43.78%
EPS beat(12)10
Avg EPS beat(12)34.6%
EPS beat(16)13
Avg EPS beat(16)24.83%
Revenue beat(2)1
Avg Revenue beat(2)-1.07%
Min Revenue beat(2)-3.63%
Max Revenue beat(2)1.5%
Revenue beat(4)3
Avg Revenue beat(4)0.39%
Min Revenue beat(4)-3.63%
Max Revenue beat(4)2.51%
Revenue beat(8)5
Avg Revenue beat(8)-0.35%
Revenue beat(12)5
Avg Revenue beat(12)-1.28%
Revenue beat(16)7
Avg Revenue beat(16)-1.32%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-9.09%
EPS NQ rev (3m)-9.09%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-2.4%
Revenue NQ rev (3m)-2.4%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.25 | ||
| Fwd PE | 6.35 | ||
| P/S | 0.32 | ||
| P/FCF | 9.28 | ||
| P/OCF | 5.53 | ||
| P/B | 0.62 | ||
| P/tB | 0.74 | ||
| EV/EBITDA | 4.04 |
EPS(TTM)1.38
EY13.8%
EPS(NY)1.58
Fwd EY15.76%
FCF(TTM)1.08
FCFY10.78%
OCF(TTM)1.81
OCFY18.07%
SpS31.52
BVpS16.16
TBVpS13.58
PEG (NY)0.15
PEG (5Y)N/A
Graham Number22.4
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.69% | ||
| ROE | 13.7% | ||
| ROCE | 5.16% | ||
| ROIC | 4.08% | ||
| ROICexc | 5.21% | ||
| ROICexgc | 6.05% | ||
| OM | 3.87% | ||
| PM (TTM) | 7.02% | ||
| GM | 67.2% | ||
| FCFM | 3.42% |
ROA(3y)-1.25%
ROA(5y)2.75%
ROE(3y)-3.26%
ROE(5y)5.55%
ROIC(3y)5.22%
ROIC(5y)9.29%
ROICexc(3y)6.41%
ROICexc(5y)12.52%
ROICexgc(3y)8.32%
ROICexgc(5y)17.24%
ROCE(3y)6.61%
ROCE(5y)11.76%
ROICexgc growth 3Y-45.58%
ROICexgc growth 5Y-28.67%
ROICexc growth 3Y-42.83%
ROICexc growth 5Y-26.9%
OM growth 3Y-34.86%
OM growth 5Y-23.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-2.13%
F-Score6
Asset Turnover1.1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 4.29 | ||
| Debt/EBITDA | 1.8 | ||
| Cap/Depr | 64.7% | ||
| Cap/Sales | 2.31% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 76.96% | ||
| Profit Quality | 48.67% | ||
| Current Ratio | 2.15 | ||
| Quick Ratio | 1.45 | ||
| Altman-Z | 3.78 |
F-Score6
WACC7.45%
ROIC/WACC0.55
Cap/Depr(3y)74.52%
Cap/Depr(5y)79.94%
Cap/Sales(3y)2.68%
Cap/Sales(5y)2.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.29%
EPS 3Y-41.01%
EPS 5Y-22.85%
EPS Q2Q%100%
EPS Next Y49.72%
EPS Next 2Y36.15%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.1%
Revenue growth 3Y-13.71%
Revenue growth 5Y-6.47%
Sales Q2Q%-15.33%
Revenue Next Year-11.95%
Revenue Next 2Y-5.71%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-28.1%
EBIT growth 3Y-43.79%
EBIT growth 5Y-28.27%
EBIT Next Year155.65%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y39.66%
FCF growth 3Y-1.31%
FCF growth 5Y-8.9%
OCF growth 1Y-0.72%
OCF growth 3Y-7.59%
OCF growth 5Y-8.88%
NU SKIN ENTERPRISES INC - A / NUS FAQ
Can you provide the ChartMill fundamental rating for NU SKIN ENTERPRISES INC - A?
ChartMill assigns a fundamental rating of 5 / 10 to NUS.
Can you provide the valuation status for NU SKIN ENTERPRISES INC - A?
ChartMill assigns a valuation rating of 9 / 10 to NU SKIN ENTERPRISES INC - A (NUS). This can be considered as Undervalued.
Can you provide the profitability details for NU SKIN ENTERPRISES INC - A?
NU SKIN ENTERPRISES INC - A (NUS) has a profitability rating of 4 / 10.
What is the valuation of NU SKIN ENTERPRISES INC - A based on its PE and PB ratios?
The Price/Earnings (PE) ratio for NU SKIN ENTERPRISES INC - A (NUS) is 7.25 and the Price/Book (PB) ratio is 0.62.
Is the dividend of NU SKIN ENTERPRISES INC - A sustainable?
The dividend rating of NU SKIN ENTERPRISES INC - A (NUS) is 4 / 10 and the dividend payout ratio is 10.87%.